Neurology Services Market Size, Share, and Industry Analysis, By Service Type (Diagnostic Services, Monitoring Services, Therapeutic Services, Surgical Services, and Others), By Indication (Alzheimer\'s Disease, Parkinson\'s Disease, Seizure, Epilepsy, Stroke, Multiple Sclerosis, and Others), By Service Provider (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Neurology services refer to a wide range of services provided by neurologists, which includes evaluating patients through comprehensive medical histories and neurological examinations, ordering and interpreting diagnostic tests such as magnetic resonance imaging (MRI) and electroencephalography (EEG), prescribing medications, and recommending physical therapy or other treatments. Common conditions treated or diagnosed under neurology services include headaches, stroke, dementia, seizures, Parkinson's disease, multiple sclerosis, and neuromuscular disorders. Neurologists work closely with other specialists, such as neurosurgeons, if a patient requires surgery. Their goal is to accurately diagnose neurological issues and develop the most effective treatment plan to manage symptoms and improve a patient's quality of life.

Market growth is primarily attributed to the increasing incidence of neurological disorders such as Alzheimer's disease, dementia, Parkinson's disease, stroke, seizures, and others. The burden of such neurological diseases or conditions is driving the demand for diagnostic and treatment services, which is anticipated to boost the market growth during the forecast period. 

• For instance, as of June 2024, the Parkinson's Foundation reported that around 1 million individuals in the U.S. currently have Parkinson's disease (PD), and this number is projected to rise to 1.2 million by 2030. Furthermore, the Parkinson's Foundation reported that 10 million individuals worldwide have Parkinson's disease (PD) across the globe.

The incidence of these diseases is further increasing awareness and fueling the demand for early detection of such conditions and their diagnosis and treatment rates. This is anticipated to boost the demand for neurology services, driving market growth in the coming years.

The COVID-19 pandemic had a negative impact on the neurology services market in 2020. The pandemic led to a decreased number of patient visits, leading to reduced consultations and diagnosis rates of neurological conditions during the pandemic. Furthermore, there was a decline in the number of outdoor visits and other procedures globally, which led to a decrease in the number of neurology services, declining the market growth in 2020.

• For instance, as per the article published by Elsevier B.V. in March 2021, 80.0% of neurologists reported a 25-75% decline in outdoor visits and electroencephalography (EEG) during the pandemic.

Segmentation

Key Insights

The report covers the following key insights:

• Incidence of Key Diseases, By Key Countries/Region, 2023
• Overview: Advancements in the Neurology Services Market
• Key Industry Developments (Mergers, Acquisitions, Partnerships)
• Impact of COVID-19 on the Market   

Analysis by Service Type

Based on the service type, the market is segregated into diagnostic services, monitoring services, therapeutic services, surgical services, and others. The therapeutic services segment is projected to account for a significant share of the global neurology services market during the forecast period. The growth of this segment is attributed to a high burden of conditions, such as Alzheimer's disease, Parkinson's disease, stroke, mental health disorders, and other neurological diseases, driving demand for treatment services to manage these conditions. Furthermore, breakthroughs in therapies, such as deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), gene therapy, and refined drug treatments, are offering new, more effective ways to manage neurological disorders, improving patient outcomes and quality of life.

• For instance, as per the article published by the Mass General Brigham Incorporated in June 2024, deep brain stimulation (DBS) has shown promise as an effective treatment for managing symptoms of Parkinson’s disease (PD).

On the other hand, the diagnostic services segment is anticipated to grow at a substantial CAGR during the forecast period. There is an increasing emphasis on early diagnosis of neurological conditions to enable timely intervention and management. Diagnostic centers and hospitals are incorporating high-resolution imaging and automated analysis tools to enhance diagnostic accuracy. This is expected to surge the segment growth in the coming years.

Regional Analysis

To gain extensive insights into the market, Download for Customization

The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the neurology services market during the forecast period. The market growth is primarily attributed to the high burden of neurological diseases such as Alzheimer's disease and Parkinson's disease (PD) in the region. These conditions are stimulating the key players to focus on providing multiple neurology services in the region. Moreover, the well-developed infrastructure and high healthcare expenditure in the region are also contributing to the expansion of neurology services. These factors are expected to increase regional market growth in the coming years.

• For instance, as of June 2024, the Alzheimer's Association reported that around 7 million individuals in the U.S. currently have Alzheimer's disease, and this number is projected to rise to nearly 13 million by 2050.

Asia Pacific is projected to grow significantly during the forecast timeframe. The region's growth is mainly attributed to the increasing number of regional neurology hospitals. These increasing numbers of hospitals are further contributing to the growing medical tourism in the region to treat neurological conditions. For instance, according to the article published by IBS Hospital in June 2024, India has become a popular neurology treatment destination, with several patients opting for this country over others. This is expected to fuel the regional market growth during the forecast period.

Key Players Covered

The market consists of significant players, such as NewYork-Presbyterian Hospital, Mayo Clinic Health System, Northwestern Medicine, Sutter Health, Cleveland Clinic, Johns Hopkins University, Emory Healthcare, Barrow Neurological Institute, The President and Fellows of Harvard College, Regents of the University of Michigan, The Trustees of the University of Pennsylvania, The Regents of The University of California, and The General Hospital Corporation.

Key Industry Developments

• In February 2024, Vinehealth Digital Limited collaborated with the National Hospital for Neurology and Neurosurgery (NHNN) to provide neurology and neurosurgery services.
• In November 2023, National Park Medical Center (NPMC) launched Access TeleCare, a new teleneurology service that further localized access to expert care.
• In March 2021, Artemis Hospitals announced the launch of one-of-its-kind Neuro Sub Speciality Clinics in Gurugram for patients suffering from neurological disorders under the 'Integrated Practicing Units' concept.